HydroGraph Releases CEO Letter to Shareholders
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCBQ: HGCPF) (the “Company” or “HydroGraph”), a […]
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital […]
Forty Pillars Mining Corp. Closes Private Placement of Units
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES Vancouver, B.C., Jan. […]
Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private Placement
TEL AVIV, ISRAEL / VANCOUVER, CANADA, Jan. 16, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (the “Company”), a […]
Foremost Lithium to Present at Cambridge House Vancouver Resource Investment Conference
VANCOUVER, British Columbia, Jan. 16, 2024 (GLOBE NEWSWIRE) — Foremost Lithium Resource & Technology Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost […]
Pan American Energy Commences Geophysical and Phase 3 Drill Planning At Its Flagship Project in the United States
CALGARY, Alberta, Jan. 16, 2024 (GLOBE NEWSWIRE) — Pan American Energy Corp. (CSE: PNRG | OTCQB: PAANF | FRA: SS60) […]
Traction Uranium Issues Shares in Connection with Grease River Property Option Agreement
CALGARY, Alberta, Jan. 16, 2024 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or […]
Draganfly Announces Agreement to Pilot Drone Delivery Services Program for Mass General Brigham’s Home Hospital
Just-in-time medical drone deliveries by Draganfly to include critical medicines, technical equipment, and laboratory work to benefit patient care. Boston, […]
Aduro Clean Technologies Presents at CEM AlphaNorth Capital Event and Extends Engagement with Arrowhead Business and Investment Decisions
LONDON, Ontario, Jan. 16, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) […]
Revive Therapeutics Provides Update Evaluating Bucillamine for Nerve Agent Exposure with Defence Research and Development Canada
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), […]
